Bifidumbacterin

Bifidumbacterin contains a lyophilized mass of probiotic bacteria of the strain Bifidobacterium bifidum №1 not less than 1x108 microorganisms in one dose and is available in vials of 5 and 10 doses.

Its distinctive feature is a pleasant taste and ease of use by children and adults with intestinal infections, intestinal dysbacteriosis of various origins, indigestion.

Bifidumbacterin can be successfully used to prevent the development of these conditions.

Active substance: dried mass of live bacteria of the antagonistically active strain of Bifidobacterium bifidum №1 not less than 1x108 microorganisms in one dose.

Product: lyophilized crystalline or porous mass of 5 and 10 doses in vials or packages.

The therapeutic effect of the drug Bifidumbacterin is determined by live bifidobacteria, which have antagonistic activity against a wide range of pathogenic and opportunistic microorganisms.

The predominance of bifidoflora in the microbiocenosis after taking the drug normalizes the activity of the gastrointestinal tract, improves metabolic processes, stimulates the functional activity of the digestive system, prevents the development of prolonged forms of intestinal diseases, increases nonspecific resistance.

Indications for use:

• treatment and prevention of intestinal dysbiosis, which occurs due to antibacterial, hormonal, radiation and other therapies;

• complex treatment of acute infectious diseases of the intestine (dysentery, salmonellosis, Escherichia coli, viral diarrhea, etc.);

• treatment of convalescents after acute intestinal infections;

• treatment of intestinal dysfunctions of staphylococcal and unknown etiology;

• comprehensive treatment of acute and chronic intestinal diseases (enterocolitis, colitis) with a violation of the microflora.

Course of treatment: In intestinal diseases - 2-3 weeks, for prophylactic purposes - 5 doses 1-2 times a day for 2-3 weeks.

Side effects: Not described.

Contraindications: Not established.